Heart Institute (InCor), Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Hospital Laboratory of Neuromodulation, Spaulding Rehabilitation, Harvard Medical School, Boston, USA.
Clinics (Sao Paulo). 2014;69 Suppl 1(Suppl 1):73-5. doi: 10.6061/clinics/2014(sup01)12.
Solid organ transplantation has greatly improved survival in children with end-stage disease, becoming one of the main treatment options in this population. Nonetheless, there are significant challenges associated with validating and optimizing the effects of these interventions in clinical trials. Therefore, we reviewed the main issues related to conducting clinical transplantation research in children. We divided these challenges into three different categories: (i) challenges related to surgical techniques and anesthetic procedures, (ii) challenges related to post-transplant care and (iii) challenges specific to a particular population group and disease type. Some of the observed burdens for clinical research in this field are related to the limitations of conducting studies with a placebo or sham procedure, determining the standard of care for a control group, low prevalence of cases, ethical concerns related to use of a placebo control group and lack of generalizability from animal studies and clinical trials conducted in adult populations. To overcome some of these barriers, it is necessary to utilize alternative clinical trial designs, such as observational studies or non-inferiority trials, and to develop multicenter collaborations to increase the recruitment rate. In conclusion, the lack of robust data related to pediatric transplantation remains problematic, and further clinical trials are needed to develop more efficacious and safer treatments.
实体器官移植大大提高了终末期疾病患儿的生存率,成为该人群的主要治疗选择之一。然而,在临床试验中验证和优化这些干预措施的效果存在重大挑战。因此,我们回顾了在儿童中进行临床移植研究的主要问题。我们将这些挑战分为三类:(i)与手术技术和麻醉程序相关的挑战,(ii)与移植后护理相关的挑战,以及(iii)特定人群和疾病类型特有的挑战。在该领域的临床研究中观察到的一些负担与使用安慰剂或假手术进行研究的局限性、确定对照组的标准护理、病例的低患病率、与使用安慰剂对照组相关的伦理问题以及缺乏从动物研究和成人人群中进行的临床试验的普遍性有关。为了克服其中的一些障碍,有必要利用替代临床试验设计,如观察性研究或非劣效性试验,并开展多中心合作以提高招募率。总之,与儿科移植相关的缺乏稳健数据仍然是一个问题,需要进一步的临床试验来开发更有效和更安全的治疗方法。